Lipid screening in childhood and adolescence for detection of multifactorial dyslipidemia: Evidence report and systematic review for the US Preventive Services Task Force

JAMA - Journal of the American Medical Association

Volumn 316, Issue 6, 2016, Pages 634-644

  Lozano, Paula ^a   Henrikson, Nora B ^a   Morrison, Caitlin C ^a   Dunn, John ^a   Nguyen, Matt ^a   Blasi, Paula R ^a   Whitlock, Evelyn P ^b  

^a KAISER PERMANENTE   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTILIPEMIC AGENT; BIOLOGICAL MARKER;

AGE DISTRIBUTION; ATHEROSCLEROSIS; BRAIN ISCHEMIA; DIAGNOSTIC VALUE; DIETARY INTAKE; DISEASE ASSOCIATION; DYSLIPIDEMIA; GROWTH RATE; HEART INFARCTION; HUMAN; MORTALITY; MULTIFACTORIAL DYSLIPIDEMIA; NUTRITIONAL STATUS; OBESITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT COUNSELING; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUALITY CONTROL; REVIEW; SCREENING TEST; SYSTEMATIC REVIEW; TREATMENT RESPONSE; ADOLESCENT; ADVERSE EFFECTS; ADVISORY COMMITTEE; AGE; BLOOD; CHILD; DYSLIPIDEMIAS; FEMALE; INFANT; LIFESTYLE; MALE; MASS SCREENING; MYOCARDIAL INFARCTION; NEWBORN; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PROCEDURES; STROKE; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADVISORY COMMITTEES; AGE DISTRIBUTION; AGE FACTORS; ATHEROSCLEROSIS; BIOMARKERS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; INFANT; INFANT, NEWBORN; LIFE STYLE; MALE; MASS SCREENING; MYOCARDIAL INFARCTION; PREVENTIVE HEALTH SERVICES; STROKE; UNITED STATES; YOUNG ADULT;

EID: 84981156416     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.6423     Document Type: Review

References (44)

1. Helfand M, Carson S. Screening for Lipid Disorders in Adults: Selective Update of 2001 US Preventive Services Task Force Review: Evidence Synthesis No. 49. Rockville, MD: Agency for Healthcare Research and Quality; 2008. AHRQ publication 08-05114-EF-1.
2. Cook S, Auinger P, Huang TT. Growth curves for cardio-metabolic risk factors in children and adolescents. J Pediatr. 2009;155(3) (suppl 6):6.e15-6.e26.
3. National Cholesterol Education Program. Highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89(3):495-501.
4. Gidding SS, Barton BA, Dorgan JA, et al. Higher self-reported physical activity is associated with lower systolic blood pressure: the Dietary Intervention Study in Childhood (DISC). Pediatrics. 2006;118(6):2388-2393.
5. Wong ND, Hei TK, Qaqundah PY, Davidson DM, Bassin SL, Gold KV. Television viewing and pediatric hypercholesterolemia. Pediatrics. 1992;90(1 pt 1):75-79.
6. Raman A, Sharma S, Fitch MD, Fleming SE. Anthropometric correlates of lipoprotein profile and blood pressure in high BMI African American children. Acta Paediatr. 2010;99(6):912-919.
7. Ice CL, Murphy E, Cottrell L, Neal WA. Morbidly obese diagnosis as an indicator of cardiovascular disease risk in children: results from the CARDIAC Project. Int J Pediatr Obes. 2011;6(2):113-119.
8. Kit BK, Kuklina E, Carroll MD, Ostchega Y, Freedman DS, Ogden CL. Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012. JAMA Pediatr. 2015;169(3):272-279.
9. Haney EM, Huffman LH, Bougatsos C, Freeman M, Steiner RD, Nelson HD. Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force. Pediatrics. 2007;120(1):e189-e214.
10. Magnussen CG, Raitakari OT, Thomson R, et al. Utility of currently recommended pediatric dyslipidemia classifications in predicting dyslipidemia in adulthood: evidence from the Childhood Determinants of Adult Health (CDAH) study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study. Circulation. 2008;117(1):32-42.
11. Juhola J, Magnussen CG, Viikari JS, et al. Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: the Cardiovascular Risk in Young Finns Study. J Pediatr. 2011;159(4):584-590.
12. US Preventive Services Task Force. Screening for lipid disorders in children: US Preventive Services Task Force recommendation statement. Pediatrics. 2007;120(1):e215-e219.
13. Lozano P, Henrikson NB, Dunn J, et al. Lipid screening in childhood and adolescence for detection of familial hypercholesterolemia: evidence report and systematic review for the US Preventive Services Task Force. JAMA. doi:10.1001/jama.2016.6176.
14. Harris RP, Helfand M, Woolf SH, et al; Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3) (suppl):21-35.
15. US Preventive Services Task Force. US Preventive Services Task Force Procedure Manual. Rockville, MD: US Preventive Services Task Force; 2015.
16. Lozano P, Henrikson NB, Morrison CC, et al. Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia: A Systematic Evidence Review for the US Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2016.
17. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: summary report. Pediatrics. 2011;128(suppl 5):S213-S256.
18. United Nations Development Programme. Human Development Index: 2013 Rankings. http://hdr.undp.org/en/2013-report. Accessed July 14, 2016.
19. Garcia RE, Moodie DS. Routine cholesterol surveillance in childhood. Pediatrics. 1989;84(5):751-755.
20. Kit BK, Carroll MD, Lacher DA, Sorlie PD, DeJesus JM, Ogden C. Trends in serum lipids among US youths aged 6 to 19 years, 1988-2010. JAMA. 2012;308(6):591-600.
21. Centers for Disease Control and Prevention. Prevalence of abnormal lipid levels among youths-United States, 1999-2006. MMWR Morb Mortal Wkly Rep. 2010;59(2):29-33.
22. Ford ES, Li C, Zhao G, Mokdad AH. Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the United States. Circulation. 2009;119(8):1108-1115.
23. Margolis KL, Greenspan LC, Trower NK, et al. Lipid screening in children and adolescents in community practice: 2007 to 2010. Circ Cardiovasc Qual Outcomes. 2014;7(5):718-726.
24. Ritchie SK, Murphy EC, Ice C, et al. Universal vs targeted blood cholesterol screening among youth: the CARDIAC Project. Pediatrics. 2010;126(2):260-265.
25. Wong H, Chahal N, Manlhiot C, Niedra E, McCrindle BW. Flaxseed in pediatric hyperlipidemia: a placebo-controlled, blinded, randomized clinical trial of dietary flaxseed supplementation for children and adolescents with hypercholesterolemia. JAMA Pediatr. 2013;167(8):708-713.
26. DISC Collaborative Research Group. Dietary Intervention Study in Children (DISC) with elevated low-density-lipoprotein cholesterol: design and baseline characteristics. Ann Epidemiol. 1993;3(4):393-402.
27. Writing Group for the DISC Collaborative Research Group. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. JAMA. 1995;273(18):1429-1435.
28. Obarzanek E, Kimm SY, Barton BA, et al; DISC Collaborative Research Group. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: 7-year results of the Dietary Intervention Study in Children (DISC). Pediatrics. 2001;107(2):256-264.
29. Dorgan JF, Liu L, Barton BA, et al. Adolescent diet and metabolic syndrome in young women: results of the Dietary Intervention Study in Children (DISC) follow-up study. J Clin Endocrinol Metab. 2011;96(12):E1999-E2008.
30. Obarzanek E, Hunsberger SA, Van Horn L, et al. Safety of a fat-reduced diet: the Dietary Intervention Study in Children (DISC). Pediatrics. 1997;100(1):51-59.
31. Lavigne JV, Brown KM, Gidding S, et al. A cholesterol-lowering diet does not produce adverse psychological effects in children: 3-year results from the Dietary Intervention Study in Children. Health Psychol. 1999;18(6):604-613.
32. Saydah S, Bullard KM, Imperatore G, Geiss L, Gregg EW. Cardiometabolic risk factors among US adolescents and young adults and risk of early mortality. Pediatrics. 2013;131(3):e679-e686.
33. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analysis. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed July 14, 2016.
34. National Center for Health Statistics. Analytic and Reporting Guidelines: the Third National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Hyattsville, MD: National Center for Health Statistics; 1996.
35. Van Horn L, Obarzanek E, Friedman LA, Gernhofer N, Barton B. Children's adaptations to a fat-reduced diet: the Dietary Intervention Study in Children (DISC). Pediatrics. 2005;115(6):1723-1733.
36. Daniels SR. Screening for familial hypercholesterolemia: what is the most effective strategy? Nat Clin Pract Cardiovasc Med. 2008;5(3):130-131.
37. Daniels SR, Greer FR; Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008;122(1):198-208.
38. Martínez-Gómez D, Eisenmann JC, Gómez-Martínez S, Veses A, Marcos A, Veiga OL. Sedentary behavior, adiposity and cardiovascular risk factors in adolescents: the AFINOS study. Rev Esp Cardiol. 2010;63(3):277-285.
39. Vinci SR, Rifas-Shiman SL, Cheng JK, Mannix RC, Gillman MW, de Ferranti SD. Cholesterol testing among children and adolescents during health visits. JAMA. 2014;311(17):1804-1807.
40. Joyce N, Wellenius GA, Dore DD, Newburger JW, Zachariah JP. Patterns of lipid lowering therapy among children ages 8-20 years. J Pediatr. 2015;167(1):113-9.e1.
41. Clarke WR, Schrott HG, Leaverton PE, Connor WE, Lauer RM. Tracking of blood lipids and blood pressures in school age children: the Muscatine study. Circulation. 1978;58(4):626-634.
42. Di Angelantonio E, Sarwar N, Perry P, et al; Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993-2000.
43. Sniderman AD, Williams K, Contois JH, et al. Ameta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes. 2011;4(3):337-345.
44. Robinson JG, Wang S, Smith BJ, Jacobson TA. Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. J AmColl Cardiol. 2009;53(4):316-322.